A Clinical Efficacy Prediction Study of Acupuncture treatment for Migraine Based on Neuroimage and COMT Gene Polymorphism

Chengdu University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1.Aged from 18 to 65 years;
•2.Migraine without aura patients: meetting the ICHD-3 2018 edition diagnostic criteria for migraine (without aura) published by the International Headache Society;
•3.Tension-type headache patients: meetting the ICHD-3 2018 edition diagnostic criteria for primary tension-type headache published by the International Headache Society;
•4.Right handedness;
•5.With a history of migraine or tension-type headache for over 6 months;
•6.Migraine or tension-type headache attacks more than once a month in the past 3 months;
•7.Did not receive no acupuncture treatment in the past 3 months;
•8.Did not take any preventive, long-acting analgesics, psychotropic drugs (such as Prozac and estazolam eurodin) or vasoactive drugs for migraine or tension-type headache in the past 3 months;
•9.The informed consent is signed by the patient himself or his immediate family member.
•Note: Only those who meet each of the above 9 criteria can be included in the study.

•1.Suffering from other pain conditions;
•2.Suffering from mental disorders (such as primary anxiety, primary depression, schizophrenia, etc.);
•3.Suffering from cognitive and consciousness disorder who cannot comply with the experiment procedure;
•4.Suffering from cancer, circulation, phumalnory, urinary, hematopoietic and other systems serious primary diseases;
•5.Being pregnant or lactating;
•6.Patients who have a history of alcohol or drug abuse or drug addiction;
•7.Having acupuncture contradictions;
•8.Having MRI contraindications (such as there are metal implants in the body, or suffer from claustrophobia syndrome, etc.).
•Note: Those who meet any of the above 8 criteria should be excluded in the study.

发起方

Chengdu University of Traditional Chinese Medicine